| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |